Sign in

CIK 0000899460

  • Large accelerated filer

MANNKIND CORP

Sign in to watch
Ticker
MNKD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
133607736
Phone
+1 818-661-5000
Business address
1 CASPER STREET, DANBURY, CT, 06810
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$256,334
in 2 filings, $256K under 10b5-1 plans

Net −$256,334. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Binder Steven B. −$256K Director sold 9% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-05-15 KRESA KENT Director Grant or award · Restricted Stock Unit +35,047 35,047
2023-05-25 KRESA KENT Director Grant or award · Restricted Stock Unit +47,393 47,393
2022-05-10 KRESA KENT Director Grant or award · Restricted Stock Unit +45,045 45,045
2021-05-20 KRESA KENT Director Grant or award · Restricted Stock Unit +33,860 33,860
2021-05-20 KRESA KENT Director Grant or award · Restricted Stock Unit +11,338 11,338
2020-05-21 KRESA KENT Director Grant or award · Restricted Stock Unit +88,235 88,235
2020-05-21 KRESA KENT Director Grant or award · Restricted Stock Unit +38,760 38,760
2019-05-14 KRESA KENT Director Grant or award · Restricted Stock Unit +72,115 72,115
2019-05-14 KRESA KENT Director Grant or award · Restricted Stock Unit +33,557 33,557
2018-06-14 KRESA KENT Director Grant or award +41,666 $1.92 $80K 274,541
2018-05-16 KRESA KENT Director Grant or award · Restricted Stock Unit +65,200 65,200
2017-05-18 KRESA KENT Director Grant or award · Restricted Stock Unit +65,200 65,200

Page 1 of 1 · 12 trades